Viewing Study NCT03623932


Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-01-25 @ 2:07 AM
Study NCT ID: NCT03623932
Status: UNKNOWN
Last Update Posted: 2020-03-23
First Post: 2018-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease
Sponsor: University Hospital, Grenoble
Organization:

Study Overview

Official Title: Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease
Status: UNKNOWN
Status Verified Date: 2020-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HYPNOCROHN
Brief Summary: Evaluation of hypnosis therapy efficacy in addition to pharmacologic standard treatment of Croh disease during remission by the evaluation of quality of life;
Detailed Description: Crohn disease is defined as an inflammatory chronic disease of the bowel characterize by intermittent flare-ups and remission periods.

Crohn disease is due to genetic and environmental factors such as stress. Stress is an important aggravation factor of the disease symptoms which can stop a remission period and induce a relapse into a flare-up period.

Hypnosis is a non-medicinal technic which already show efficacy in the treatment of functional digestive troubles. These diseases are bio/psycho/social models such as Crohn disease.

Hypnosis can reduce visceral pain sensibility, reduce stress and reduce pro-inflammatory cytokines liberation into intestinal mucosa.

Though, only few data are available on hypnosis interest in the treatment of Crohn disease and inflammatory bowel diseases as it is often isolated clinical case report.

One study on patients with rectocolitis in remission period has been done recently and show that hypnosis increased the duration of the remission period.

The principal objective of this study is to evaluate hypnosis efficacy in term of quality of life for patients with Crohn disease during remission.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: